From stem cells and cadaveric matrix to engineered organs

Current Opinion in Biotechnology

Volumn 20, Issue 5, 2009, Pages 598-605

  Taylor, Doris A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; CELL TECHNOLOGY; CLINICAL TREATMENTS; COMPLEX TISSUES; DRUG DISCOVERY; DRUG SCREENING; HEART FAILURE; HUMAN CELLS; MATRIX; ORGAN TRANSPLANTS; PROGENITOR CELL; STEM CELL;

EQUIPMENT TESTING;

TISSUE ENGINEERING;

TISSUE SCAFFOLD;

ARTIFICIAL HEART; AUTOLOGOUS STEM CELL TRANSPLANTATION; CADAVER DONOR; CARDIOVASCULAR DISEASE; CELL THERAPY; DRUG RESEARCH; DRUG SCREENING; GRAFT RECIPIENT; HEART FAILURE; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; ARTIFICIAL ORGANS; CADAVER; HEART TRANSPLANTATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

IPS;

EID: 70449686553     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2009.10.016     Document Type: Review

References (38)

1. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., Roberts D.J., Huang P.L., Domian I.J., and Chien K.R. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460 (2009) 113-117
2. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., Thomson J.A., and Kamp T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104 (2009) e30-41
3. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., and Taylor D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14 (2008) 213-221
4. Eschenhagen T., Didie M., Munzel F., Schubert P., Schneiderbanger K., and Zimmermann W.H. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97 Suppl 1 (2002) I146-152
5. Masuda S., Shimizu T., Yamato M., and Okano T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60 (2008) 277-285
6. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-171
7. Haffner S.M. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. Int J Clin Pract Suppl 129 (2002) 33-39
8. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., Franklin B.A., Goldstein L.B., Greenland P., Grundy S.M., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002) 388-391
9. Wyatt S.B., Winters K.P., and Dubbert P.M. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 331 (2006) 166-174
10. Juonala M., Viikari J., Rasanen L., Helenius H., Pietikainen M., and Raitakari O. Young adults with family history of coronary heart disease have increased arterial vulnerability to metabolic risk factors: the Cardiovascular Risk in Young Finns Study. Arterioscl Thromb Vasc Biol 26 (2006) 1376-1382
11. Association AH. Heart Attack and Angina Statistics (2009)
12. Taylor D.A., and Robertson M.J. The basics of cell therapy to treat cardiovascular disease: one cell does not fit all. Rev Esp Cardiol 62 (2009) 1032-1044
13. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bohm M., and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
14. Wang J.-S., Shum-Tim D., Chedrawy E., Eliopoulis N., Galipeau J., and Chiu R.C.-J. Marrow stromal cells for cellular cardiomyoplasty: the importance of microenvironment for milieu dependent differentiation {abstract}. Circulation 102 18 suppl II (2000) 683
15. Nussbaum J., Minami E., Laflamme M.A., Virag J.A., Ware C.B., Masino A., Muskheli V., Pabon L., Reinecke H., and Murry C.E. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21 (2007) 1345-1357
16. Ott H.C., Matthiesen T.S., Brechtken J., Grindle S., Goh S.K., Nelson W., and Taylor D.A. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S27-39
17. Zenovich A.G., Davis B.H., and Taylor D.A. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Handb Exp Pharmacol (2007) 117-165
18. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., Zuba-Surma E.K., Al-Mallah M., and Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
19. Hristov M., Heussen N., Schober A., and Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 10 (2006) 727-733
20. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., Khianey R., Sheiban I., Bartunek J., Vanderheyden M., Kim H.S., Kang H.J., Strauer B.E., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50 (2007) 1761-1767
21. Anversa P., and Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415 (2002) 240-243
22. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100 (2003) 12313-12318
23. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., Beltrami C.A., Bussani R., Beltrami A.P., Quaini F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102 (2005) 8692-8697
24. Cai C.L., Martin J.C., Sun Y., Cui L., Wang L., Ouyang K., Yang L., Bu L., Liang X., Zhang X., et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454 (2008) 104-108
25. Zhou B., Ma Q., Rajagopal S., Wu S.M., Domian I., Rivera-Feliciano J., Jiang D., von Gise A., Ikeda S., Chien K.R., et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454 (2008) 109-113
26. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., Giacomello A., Abraham M.R., and Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
27. Kobashigawa J.A., and Patel J.K. Immunosuppression for heart transplantation: where are we now?. Nat Clin Pract Cardiovasc Med 3 (2006) 203-212
28. Eschenhagen T., and Zimmermann W.H. Engineering myocardial tissue. Circ Res 97 (2005) 1220-1231
29. Radisic M., Deen W., Langer R., and Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288 (2005) H1278-1289
30. Sekine H., Shimizu T., Kosaka S., Kobayashi E., and Okano T. Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J Heart Lung Transplant 25 (2006) 324-332
31. Furuta A., Miyoshi S., Itabashi Y., Shimizu T., Kira S., Hayakawa K., Nishiyama N., Tanimoto K., Hagiwara Y., Satoh T., et al. Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res 98 (2006) 705-712
32. Miyagawa S., Sawa Y., Sakakida S., Taketani S., Kondoh H., Memon I.A., Imanishi Y., Shimizu T., Okano T., and Matsuda H. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 80 (2005) 1586-1595
33. Park H., Radisic M., Lim J.O., Chang B.H., and Vunjak-Novakovic G. A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev Biol Anim 41 (2005) 188-196
34. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12 (2006) 452-458
35. Sekine H., Shimizu T., Yang J., Kobayashi E., and Okano T. Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation 114 (2006) I87-93
36. Robinson K.A., Li J., Mathison M., Redkar A., Cui J., Chronos N.A., Matheny R.G., and Badylak S.F. Extracellular matrix scaffold for cardiac repair. Circulation 112 (2005) I135-143
37. Caspi O., Itzhaki I., Arbel G., Kehat I., Gepstien A., Huber I., Satin J., and Gepstein L. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev (2008)
38. Zimmermann W.H., Didie M., Wasmeier G.H., Nixdorff U., Hess A., Melnychenko I., Boy O., Neuhuber W.L., Weyand M., and Eschenhagen T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106 (2002) I151-157